SummaryObjectivesTo analyze the impact of late presentation (LP) on overall mortality and causes of death and describe LP trends and risk factors (2004–2013).MethodsCox models and logistic regression were used to analyze data from a nation-wide cohort in Spain. LP is defined as being diagnosed when CD4 < 350 cells/ml or AIDS.ResultsOf 7165 new HIV diagnoses, 46.9% (CI95%:45.7–48.0) were LP, 240 patients died.First-year mortality was the highest (aHRLP.vs.nLP = 10.3[CI95%:5.5–19.3]); between 1 and 4 years post-diagnosis, aHRLP.vs.nLP = 1.9(1.2–3.0); and >4 years, aHRLP.vs.nLP = 1.5(0.7–3.1).First-year's main cause of death was HIV/AIDS (73%); and malignancies among those surviving >4 years (32%). HIV/AIDS-related deaths were more likely in L...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
AbstractObjectiveTo present surveillance data on advanced disease (AD) and late presentation (LP) of...
The antiretroviral treatment has supposed a decrease in HIV-related mortality. We assessed factors r...
To analyze the impact of late presentation (LP) on overall mortality and causes of death and describ...
With the purpose of reducing the well-known negative impact of late presentation (LP) on people livi...
BACKGROUND: We aimed at evaluating frequency and factors associated with late presentation and adva...
Background: We aimed at evaluating frequency and factors associated with late presentation and advan...
Cohorte de la Red de InvestigacioÂn en Sida (CoRIS).[Objetives] Outcomes of people living with HIV (...
Background: Few studies have monitored late presentation (LP) of HIV infection over the European ...
BACKGROUND: We examined specific causes of mortality in human immunodeficiency virus type 1 (HIV-1)-...
Abstract Background We aimed at evaluating frequency and factors associated with late presentation a...
BACKGROUND: Patterns of cause-specific mortality in individuals infected with human immunodeficiency...
Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific d...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
BACKGROUND: Patterns of cause-specific mortality in individuals infected with human immunodeficiency...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
AbstractObjectiveTo present surveillance data on advanced disease (AD) and late presentation (LP) of...
The antiretroviral treatment has supposed a decrease in HIV-related mortality. We assessed factors r...
To analyze the impact of late presentation (LP) on overall mortality and causes of death and describ...
With the purpose of reducing the well-known negative impact of late presentation (LP) on people livi...
BACKGROUND: We aimed at evaluating frequency and factors associated with late presentation and adva...
Background: We aimed at evaluating frequency and factors associated with late presentation and advan...
Cohorte de la Red de InvestigacioÂn en Sida (CoRIS).[Objetives] Outcomes of people living with HIV (...
Background: Few studies have monitored late presentation (LP) of HIV infection over the European ...
BACKGROUND: We examined specific causes of mortality in human immunodeficiency virus type 1 (HIV-1)-...
Abstract Background We aimed at evaluating frequency and factors associated with late presentation a...
BACKGROUND: Patterns of cause-specific mortality in individuals infected with human immunodeficiency...
Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific d...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
BACKGROUND: Patterns of cause-specific mortality in individuals infected with human immunodeficiency...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
AbstractObjectiveTo present surveillance data on advanced disease (AD) and late presentation (LP) of...
The antiretroviral treatment has supposed a decrease in HIV-related mortality. We assessed factors r...